Document is current
Any future updates will be listed below
-
Authors
Sierksma, Annerieke https://orcid.org/0000-0001-9233-972X
Lu, Ashley
Mancuso, Renzo https://orcid.org/0000-0002-7046-3348
Fattorelli, Nicola https://orcid.org/0000-0001-5564-8179
Thrupp, Nicola
Salta, Evgenia
Zoco, Jesus https://orcid.org/0000-0003-1164-4306
Blum, David https://orcid.org/0000-0001-5691-431X
Buée, Luc
De Strooper, Bart https://orcid.org/0000-0001-5455-5819
Fiers, Mark https://orcid.org/0000-0001-5694-2409
-
Funding
Funding for this research was provided by:
Leuven Universitair Fonds
Alzheimer Research Foundation (P16017)
Fonds voor Wetenschappelijk Onderzoek (1139520N)
Fonds voor Wetenschappelijk Onderzoek (12A5316N)
Fonds voor Wetenschappelijk Onderzoek (G0C9219N)
Alzheimer's Association (AARF‐16‐442853)
KU Leuven
Vlaams Instituut voor Biotechnologie
Vlaamse Overheid
Vlaams Initiatief voor Netwerken voor Dementie Onderzoek
Geneeskundige Stichting Koningin Elisabeth
Bax‐Vanluffelen Chair for Alzheimer's Disease
Agence National Recherche (ANR‐16‐COEN‐0007)
UK Research and Innovation|MRC|Medical Research Foundation
Alzheimer Society
Alzheimer Research UK
- License Information
-
More Information
Article History
Received: 15 March 2019
Revised: 20 December 2019
Accepted: 20 December 2019
First Online: 17 January 2020
Conflict of interest
: B.D.S. is ad hoc consultant for various companies but has no direct financial interest in the current study. L.B. is consultant for Servier and Remynd. He receives research funding from UCB Pharma, but not for the work presented in the current manuscript. A.S., A.L., E.S., R.M., J.Z., D.B., and M.F. report no biomedical financial interests or potential conflicts of interest.
